Literature DB >> 582149

Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases.

J Wójcicki, B Gawrońska-Szklarz, J Kazimierczyk, Z Baskiewicz, A Raczyński.   

Abstract

The pharmacokinetics of paracetamol administered in a single dose were investigated and compared in young male and female subjects, considering follicular and luteal phase of the menstrual cycle. The mean AUC for paracetamol in the blood of female subjects was significantly increased by 39% and 51%, respectively, taking into account the follicular and luteal phase, in comparison with the AUCs of male volunteers. The peak plasma concentration revealed significantly higher values in women in both phases, by 48% and 66%, respectively. The time to reach the peak concentration was shorter by 8% in follicular phase than in males. The difference was statistically insignificant. Elimination constant decreased in follicular phase by 15% and in luteal phase by 21% in comparison with males (the difference--statistically insignificant). The paracetamol half-life was longer (although not significantly) in women than in men: in follicular phase by 29 min, i.e. 15%, and in luteal phase by 65 min, i.e. 33%. The apparent volume of distribution was found to be significantly lower in the female group by 35% and 40% in follicular and luteal phase, respectively. Comparing data obtained in the follicular and luteal phase, it was shown that the AUC was larger, peak plasma concentration was higher and biological half-life was longer in luteal phase. It is likely that the differences in some pharmacokinetic parameters between men and women, as well as in women considering both phases of menstrual cycle, might be of clinical significance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 582149

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  12 in total

1.  Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

Authors:  B Bruguerolle; M Toumi; F Faraj; D Vervloet; H Razzouk
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Salivary paracetamol elimination kinetics during the menstrual cycle.

Authors:  L Somaja; J Thangam
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

3.  Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam.

Authors:  R Jochemsen; M van der Graaff; J K Boeijinga; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

Review 4.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

5.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

Review 6.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

7.  Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.

Authors:  J O Miners; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

8.  Paracetamol pharmacokinetics during the first trimester of human pregnancy.

Authors:  L Beaulac-Baillargeon; S Rocheleau
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

Authors:  K Wilson; M Oram; C E Horth; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of paracetamol.

Authors:  J A Forrest; J A Clements; L F Prescott
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.